Vendor, Grambach, AUT
Scantox Neuro GMBH
UEI ED41XCPBEPU1, CAGE 3613N
4 awards and $21,787 obligated between December 6, 2024 and June 3, 2026, 0% under full and open competition, against 1.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Pharmaceutical Preparation ManufacturingNAICS 325412 | $21,788 |
| Testing Laboratories and ServicesNAICS 541380 | $0 |
| Medical LaboratoriesNAICS 621511 | -$0 |
How it wins
Awards by competition, set-aside and type.
| Competed Under SAP | 3 |
| Not Competed Under SAP | 1 |
| Purchase Order | 3 |
| Delivery Order | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N95D25P00029Purchase Order, December 23, 2024, Not Competed Under SAP, 1 offers | National Institutes of Health NiaNational Institutes of Health | Reagent Materials - Hydroxy Chloroquine Sulphate and Chiral Separation/PurificationNAICS 325412, PSC 6505 | $21,788 |
| 75N95022P00542Purchase Order, December 6, 2024, Competed Under SAP, 1 offers | National Institutes of Health NidaNational Institutes of Health | Tolerability Studies of Candidate Ad Drugs and Efficacy of Poly(L-Lysine Succinylated)-Hydroxychloroquine (Pls-Hcq) in a Transgenic Ad MouseNAICS 541380, PSC Q301 | $0 |
| 75N95023P00617Purchase Order, December 6, 2024, Competed Under SAP, 1 offers | National Institutes of Health NidaNational Institutes of Health | Pharmacodynamic and Tolerability Studies of Candidate Ad Drugs in a Transgenic Ad Mouse ModelNAICS 541380, PSC Q301 | $0 |
| 75N95022F00001Delivery Order, June 3, 2026, Competed Under SAP | National Institutes of Health NidaNational Institutes of Health | Experimental Validation of Candidate Alzheimer'S Disease Treatments Identified by Multi-Omics AnalysesNAICS 621511, PSC Q301 | -$0 |
- Product and service codes
- 6505 Drugs and BiologicalsQ301 Reference Laboratory Testing
- Transactions
- 9 across 4 awards